When Fundrise’s Innovation Fund (VCX) listed on the NYSE on March 19, 2026, at a net asset value of $18.97 per share, something unusual happened: retail investors briefly bid the price above $400 — a premium exceeding 20 times NAV. That euphoria has faded. But the underlying NAV math, when you run it carefully through the fund’s actual holdings and recent fundraising rounds, tells a genuinely interesting story. Financial Samurai’s founder, a multiple six-figure investor in Fundrise products who has been locked up since the listing, has published the most detailed NAV estimate yet: approximately $29 per share today, rising to $31 by the lockup expiration on September 14, 2026, and potentially $33–$40 by year-end.
The math depends almost entirely on Anthropic. VCX held Anthropic at a roughly $350 billion valuation (its February 2026 Series G) when the fund listed. Anthropic then raised $65 billion at a $965 billion post-money valuation in May 2026. After accounting for dilution — new money lowers the markup for existing shareholders — the dilution-adjusted markup on Anthropic is approximately 2.57 times. Since Anthropic represented 20.7% of the fund at listing, that single position contributes roughly 32.5 percentage points of NAV growth all by itself, taking the Anthropic slice from $3.93 per VCX share to $10.11. The next largest positions are Databricks (17.5% of the fund, modest 1.31x markup), OpenAI (10%, approximately 1.5x now with a targeted September IPO near $1 trillion), Anduril (7%, 1.84x after its $5 billion Series H), and SpaceX (5%, approximately 1.8x from its prior carrying value, now publicly traded). Add it all up and the estimated NAV grows from $19 to roughly $29 today. The lockup means existing shareholders cannot sell until September 14 at the earliest — and by then, if OpenAI’s September IPO prices near $1 trillion and Anthropic files publicly as expected, the NAV could push toward $31–$33.
For retail investors who aren’t locked up, the key takeaway is how to use NAV as a discipline. The brief $400-per-share price in March was a sentiment event, not a fundamentals event, and buying at 20x NAV is a way to lose money on a fund whose underlying assets are genuinely extraordinary. If VCX trades back near $29–$31 — closer to NAV — the calculus changes. At that level, investors are essentially buying a diversified basket of the most valuable private AI companies on the planet, including Anthropic (potentially going public), OpenAI (IPO targeted for September 2026), SpaceX (already public, SPCX), Anduril, Databricks, Ramp, and Canva, at approximately fair value. The concentration risk is real: roughly 53 cents of every dollar of new NAV created since listing came from one company, Anthropic. But for investors who want private-market AI exposure without the high minimums of traditional VC funds, VCX at or near NAV is worth watching closely in the weeks ahead as lockup expiration approaches.
